Eddie Sullivan

In The Moment ... August 21, 2020 Show 886 Hour 1

SAB Biotherapeutics in Sioux Falls announced the first step in its trial of a COVID 19 therapeutic earlier this month, dosing the first group of healthy volunteers. Today, they're announcing the trial's next step.

Science and Technology reporting is brought to you by SDN Communications, your business broadband provider. Learn more at sdncommunications.com

Eddie Sullivan Of SAB Biotherapeutics

May 15, 2020
SDPB

In The Moment … May 15, 2020 Show 818 Hour 1

Biotech companies are working to develop antibody therapies to provide protection against COVID 19 - Joining us for an update on the development of therapeutics, we welcome Eddie Sullivan, president & CEO of SAB Biotherapeutics. 

 

Eddie Sullivan

Apr 10, 2020
SDPB

In The Moment ... April 10, 2020 Show 793 Hour 2

The human body has its own, powerful immune response that fights off illness and disease. Scientists at SAB Biotherapeutics in South Dakota are working to harness nature and save lives in the fight against coronavirus. They've been doing this work for decades and were uniquely positioned to respond rapidly to the novel coronavirus outbreak.  Joining us for an update on the development of therapeutics, we welcome Eddie Sullivan, president & CEO of SAB Biotherapeutics. 

SAB Makes Progress On Therapeutic

Mar 27, 2020
SDPB

In The Moment ... March 27, 2020 Show 783 Hour 2

Eddie Sullivan is President & CEO of SAB Therapeutics in Sioux Falls. He joins us for a look at research into COVID-19 therapeutics. 

Science and Technology reporting is brought to you by SDN Communications, your business broadband provider. Learn more at sdncommunications.com

 

Working On A COVID-19 Therapeutic

Mar 11, 2020
SDPB

In The Moment ... March 10, 2020 Show 770 Hour 1

SDPB is bringing you the latest information on the coronavirus and COVID-19, including research into the nature of human disease.  Eddie Sullivan, Ph.D. is president and CEO of South Dakota's SAb Biotherapeutics and joins In the Moment to discuss the complexity of finding a solution. 

Education and Healthcare reporting on SDPB is supported by Monument Health of Rapid City

Lori Walsh

In The Moment ... June 8, 2018 Show 354 Hour 2

The USD Discovery District has its first anchor tenant - SAB Biotherapeutics, Inc.  SAB president, CEO and co-founder Eddie Sullivan talks about being the first tenant and shares his goals for the first project.  He's joined by Rich Naser, president of the USD Discovery District.